Healthcare Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis – a Retrospective Study
mediaposted on 2020-07-03, 15:07 authored by Johan Dalén, Karin Luttropp, Axel Svedbom, Christopher M. Black, Sumesh Kachroo
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.